Navigation Links
Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma
Date:7/15/2008

e) a treatment for advanced cutaneous T-cell lymphoma.

About Cephalon, Inc.

Founded in 1987, Cephalon, Inc. is an international biopharmaceutical company dedicated to the discovery, development and commercialization of innovative products in four core therapeutic areas: central nervous system, pain, oncology and addiction. A member of the Fortune 1000, Cephalon currently employs approximately 3,000 people in the United States and Europe. U.S. sites include the company's headquarters in Frazer, Pennsylvania, and offices, laboratories or manufacturing facilities in West Chester, Pennsylvania, Salt Lake City, Utah, and suburban Minneapolis, Minnesota. The company's European headquarters are located in Maisons-Alfort, France.

The company's proprietary products in the United States include: PROVIGIL(R) (modafinil) Tablets [C-IV], FENTORA(R) (fentanyl buccal tablet) [C-II], TRISENOX(R) (arsenic trioxide) injection, TREANDA, AMRIX(R) (cyclobenzaprine hydrochloride extended-release capsules), VIVITROL(R) (naltrexone for extended-release injectable suspension), GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. The company also markets numerous products internationally. Full prescribing information on its U.S. products is available at http://www.cephalon.com or by calling 1-800-896-5855.

In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. Forward-looking statements provide Cephalon's current expectations or forecasts of future events. These may include statements regarding anticipated scientific progress on its research programs; development of potential pharmaceutical products, including the results of any clinical programs with respect to TREANDA or the timing or approval of any current or future filings for regulatory approval of TREA
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Echo Therapeutics Announces Publication of Positive Clinical Data for its Symphony Transdermal Continuous Glucose Monitoring System in Journal of Diabetes Science and Technology
2. Complete Study Results Comparing CTIs OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology
3. Results Published in the Journal Cancer Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma
4. Journal of Clinical Oncology Publishes Leukine(R) Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma
5. Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community- Associated Methicillin Resistant Staphylococcus Aureus (CA-MRSA)
6. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
7. The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxters Cell-Based Pandemic, Avian Flu Vaccine
8. Biopure Phase III Orthopedic Trial Results Published in Journal of Trauma
9. New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
10. Blood Spot Technology at ZRT Highlighted in March Issue of Journal of Diabetes Science & Technology - A Convenient Alternative to Serum Testing for Health Screening
11. Anesiva Announces Publication of Phase 3 Zingo(TM) Data in the Journal Pediatrics

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)....,Nov.24/PRNewswire/--Inadditiontofamily,friendsan...lphiajurorstoherThanksgivinggratitudelist. ,, "...ltothem,"shesaidofMonday,sverdictstotaling$103mill...neskiisamong12,000womennationwidewhohavesuedWyetha...rugsPremarinandPrempro.Wisneskiandtheothervictimso...
(Date:11/24/2009)...C.,Nov.24/PRNewswire/--PharmaceuticalInstitute,ale...harmaceuticalandbiotechindustry,todayannouncedthel...enew HospitalMarketplace e-courseisthenewestadditi...es,acomprehensiveseriesofe-coursesdesignedtofillth...ledgeforcommercialprofessionals. ,, Thenewthree...
(Date:11/24/2009)...,Nov.24/PRNewswire-USNewswire/--America,spharmaceu...medicinesandvaccinestotreatorpreventHIV/AIDSandrel...ythePharmaceuticalResearchandManufacturersofAmeric...IDSDay"-aglobalawarenesscampaignthatoriginatedatth...AIDSPrevention. ,, "Wearegreatlyencouragedbythe...
Breaking Medicine Technology:Maryland Woman Thankful for Wyeth Verdicts 2Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace 2New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 2New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 3President Clinton and Mylan Chairman and CEO Robert J Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug Resistant HIV i 53873 1President Clinton and Mylan Chairman and CEO Robert J Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug Resistant HIV i 53873 2President Clinton and Mylan Chairman and CEO Robert J Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug Resistant HIV i 53873 3President Clinton and Mylan Chairman and CEO Robert J Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug Resistant HIV i 53873 4Live recordings of cell communication 53872 1Live recordings of cell communication 53872 2Does Facebook usage contribute to jealousy in relationships 3F 53869 1Does Facebook usage contribute to jealousy in relationships 3F 53869 2
...s. and ORLANDO, Fla., March 29 Boston,Scientific ...ar results from the,SPIRIT II Clinical Trial and a...IRIT II and III Trials. SPIRIT II and SPIRIT III ... with 300 and 1,002 patients respectively,designed...R) (XIENCE V(TM)),Everolimus-Eluting Coronary Sten...
...T II Trial, XIENCE V Drug Eluting Stent Demonstrat...XUS in Key Safety Endpoints, Including an 88 Perce... Years , , ORLANDO, Fla., March 29 Long-term dat...IRIT II clinical trial demonstrated that the clini...ng Coronary Stent System continued to increase bet...
Other Medicine Technology:Clinical Data Reinforce Safety and Efficacy of Boston Scientific's Two Drug- Eluting Stent Platforms 2Clinical Data Reinforce Safety and Efficacy of Boston Scientific's Two Drug- Eluting Stent Platforms 3Clinical Data Reinforce Safety and Efficacy of Boston Scientific's Two Drug- Eluting Stent Platforms 4Clinical Data Reinforce Safety and Efficacy of Boston Scientific's Two Drug- Eluting Stent Platforms 5Abbott's Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years 2Abbott's Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years 3Abbott's Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years 4Abbott's Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years 5
(Date:11/24/2009)...i School of Medicine compared the outcomes of cirr... nonalcoholic steatohepatitis (NASH) versus alcoho...y significant differences in post-transplant survi...findings are presented in the December issue of L...y-Blackwell on behalf of the American Association ...
(Date:11/24/2009)...Newswire/--SkyFoundation,Inc.,anon-profitfoundatio...abloodtestfortheearlydetectionofpancreaticcancer,t...ceptioninJune2008.TheannouncementwasmadebySheilaSk...ion,sfirstmajorfundraiser. ,, Thefoundationheld...illageClubinBloomfieldHills,Mich.Guestsheardfromsp...
(Date:11/24/2009)...--Quantros,aleadinghealthcareanalyticsanddecisions...atithaslicensedintellectualpropertyandassociatedso...tionintoQuantros,suiteofsafetyandriskmanagement(SR...intheSRMproductfamilywillenableautomatedsafetydata...healthcareprovider,sintegratedadministrativedata.T...
(Date:11/24/2009)...StateFraternalOrderofPolicedistributedturkeys,cann...k ,, PORTJERVIS,N.Y.,Nov.24/PRNewswire-USNewswi...rtnershipwiththeNewYorkStateFraternalOrderofPolice...ewYork,sChildDevelopmentCenter,ProjectDiscoveryinP...toreceivefreeturkeys,ham,chickenandothertrimmingst...
(Date:11/24/2009)...ire/--Mostpeoplelookforwardtokickingofftheholidays...endsandfamily.TheMacombCountyHealthDepartmentremin...Travelingandbeinginlargegroupsareeasywaystospreadf..., VACCINATION ,, Thefirstandmostimportantst...edagainsttheH1N1strainoftheflu.TheMacombCountyHeal...
Breaking Medicine News(10 mins):Health News:New data emerges on liver transplant survival rates 2Health News:New data emerges on liver transplant survival rates 3Health News:Sky Foundation, Inc. Raises More Than $100,000 to Find a Test for Early Detection of Pancreatic Cancer 2Health News:Quantros Licenses Adverse Event Identification Technology from University of Michigan 2Health News:Fraternal Order of Police Provides Food and Hope for Families in Port Jervis this Thanksgiving 2Health News:Tips To Enjoy a Flu-Free Holiday Season 2
...ovember issue of Developmental Psychology has expl...picture-book reading with their children, // which...them to the world outside. This is thought to be h... and spend approximately 40 minutes a day reading ...
...la will soon head for the Maldives to care for pat...s from Kerala are to leave for the Maldives courte... Promotion Consultants (ODEPC). 'The first b.... 'The Maldives has also asked us to recruit...
...d? Yes, within the brain, say researchers. Brain ...essing mechanism has never been easy. //Meditators...ntly chattering. Researchers have come up with a f...n you least expect it. We often experience that th...
...ual health campaign is targeting young adults to c...r focus is mainly on 18 to 24-year-olds. //Current...ed to carry condoms on a night out. The ?4m ca...ealth groups but pointed out that a further ?46m h...
...captured the imagination of the world as a 'repeto...joled into restoring or rejuvenating debilitating ...ientists have helped to reiterate this belief, by ... could be lauded as a 'mile stone' in stem cell re...
...opular world over for its quality poultry products...ed to a record 3.26 Billion Rupees. //However the ...rldwide epidemic brought the poultry revenues cras...Influenza' has been known to affect humans though ...
Other Medicine News:Health News:Picture Book Reading Helps Toddlers Grasp Complex Actions 2Health News:Noise In Neurons Is good 2Health News:Risk-Taking Young Urged To Carry Condoms 2Health News:Research 'Extraordinaire' To Restore Vision 2Health News:India Free From Bird Flu 2
...roalbuminuria. Self-Sampling: ,Place the Immun... will draw,the precise amount of sample needed f...munoDip will run to completion,in 3 minutes. ,...lor bands remain stable,for at least eight hours...
...tative immunoassay for urinary albumin that allows...in specific, CLIA Waived test has a sensitivity of...e results in only 3 minutes with stable viewing re...key to preventing kidney disease, the ICON®mic...
QED A350 Saliva Alcohol Test
... is here! LTF™ (Layered Thin Film) technolog... platform that is easy to read, extremely precise ...fectious Vaginitis? Infectious vaginitis is the nu...al discharge and odor are inconvenient to the pati...
Medicine Products: